Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Clinical results with the AB-180 left ventricular assist device
Autore:
Magovern, JA; Sussman, MJ; Goldstein, AH; Szydlowski, GW; Savage, EB; Westaby, S;
Indirizzi:
Allegheny Gen Hosp, Dept Cardiothorac Surg, Pittsburgh, PA 15212 USA Allegheny Gen Hosp Pittsburgh PA USA 15212 Surg, Pittsburgh, PA 15212 USA Johannesburg Gen Hosp, Johannesburg, South Africa Johannesburg Gen Hosp Johannesburg South Africa annesburg, South Africa Ohio State Univ, Sch Med, Columbus, OH 43210 USA Ohio State Univ ColumbusOH USA 43210 iv, Sch Med, Columbus, OH 43210 USA John Radcliffe Hosp, Oxford OX3 9DU, England John Radcliffe Hosp Oxford England OX3 9DU Hosp, Oxford OX3 9DU, England
Titolo Testata:
ANNALS OF THORACIC SURGERY
fascicolo: 3, volume: 71, anno: 2001, supplemento:, S
pagine: S121 - S124
SICI:
0003-4975(200103)71:3<S121:CRWTAL>2.0.ZU;2-8
Fonte:
ISI
Lingua:
ENG
Soggetto:
ACUTE MYOCARDIAL-INFARCTION; CARDIOGENIC-SHOCK; SUPPORT; EXPERIENCE; TRIAL;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
8
Recensione:
Indirizzi per estratti:
Indirizzo: Magovern, JA Allegheny Gen Hosp, Dept Cardiothorac Surg, 320 E North Ave, Pittsburgh, PA 15212 USA Allegheny Gen Hosp 320 E North Ave Pittsburgh PA USA 15212 SA
Citazione:
J.A. Magovern et al., "Clinical results with the AB-180 left ventricular assist device", ANN THORAC, 71(3), 2001, pp. S121-S124

Abstract

Background. This report reviews the initial clinical experience with the AB-180 ventricular assist device. Methods. Between Dec 1997 and July 2000, the AB-180 was implanted in 17 patients at five institutions. The mean age was 52 years (range 21 to 68 years) and 14 of 17 were male. The indications for implantation were postcardiotomy shock (12 of 17, 70%), decompensated cardiomyopathy (2 of 17, 12%), viral myocarditis (2 of 17, 12%), and acute myocardial infarction (1 of 17, 6%). Results. The mean duration of support was 8.5 days (range 1 to 28 days). In the group of 17 patients, 8 were weaned from the device and 2 underwent transplantation. Four of the weaned patients (4 of 8, 50%) and 1 of the transplant patients (1 of 2, 50%) survived. The overall weaning and survival rates were 58% (10 of 17) and 29% (5 of 17). There were no major device-related complications and no major device malfunctions. Conclusions. The AB-180 provides reliable circulatory support for reversible forms of heart failure. (C) 2001 by The Society of Thoracic Surgeons.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/20 alle ore 19:12:27